Abstract
To evaluate a new ‘two step’ method for purging T, B and neoplastic cells from hematopoietic progenitor cells (PC), PCs were collected by apheresis and some suspensions were deliberately contaminated with 2–5% breast cancer cells. PCs were first processed through CellPro columns for positive selection of cells that express CD34. After this first step, the mean CD34+ cell recovery was 68 ± 12%, and CD34+ cell purity was 61 ± 11%; CD3+ and neoplastic cell depletion were 2.1 ± 0.4 and 1.9 ± 0.4 logs, respectively. Cells were further processed through the StemSep device for direct depletion of T and B cells or of breast cancer cells. After the first and the second step, overall CD34+ cell recovery was 50 ± 7%, T and B cell removal was 4.7 ± 0.4 log and neoplastic cell purging was 4.4 ± 0.3 log, ie significantly superior to methods described in the past.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertolini, F., Thomas, T., Battaglia, M. et al. A new ‘two step’ procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant 19, 615–619 (1997). https://doi.org/10.1038/sj.bmt.1700709
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700709
Keywords
This article is cited by
-
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer
Breast Cancer Research and Treatment (2008)
-
Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells
Cancer Gene Therapy (2001)
-
Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods
Bone Marrow Transplantation (2001)
-
Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation
Bone Marrow Transplantation (2000)